Skip to the beginning of the images gallery

Takinib - ≥98%(HPLC), high purity , CAS No.1111556-37-6, Inhibitor of CDC like kinase 2;Inhibitor of interleukin 1 receptor associated kinase 1;Inhibitor of interleukin 1 receptor associated kinase 4;Inhibitor of mitogen-activated protein kinase kinase kinase 7

Moligand™
≥98%(HPLC)

CAS#: 1111556-37-6
Formula: C₁₈H₁₈N₄O₂
Molecular Weight: 322.37
EC Number: 841-675-9
PubChem CID: 37750349

Item Number

T288176

Grouped product items
SKU	Size	Availability	Price
T288176-5mg	5mg	In stock	$78.90
T288176-10mg	10mg	In stock	$147.90
T288176-25mg	25mg	In stock	$333.90
T288176-50mg	50mg	In stock	$444.90
T288176-100mg	100mg	In stock	$741.90

Potent and selective TAK1/MAP3K7 kinase inhibitor

View related series

CDC like kinase 2 Inhibitor interleukin 1 receptor associated kinase 1 Inhibitor interleukin 1 receptor associated kinase 4 Inhibitor mitogen-activated protein kinase kinase kinase 7 Inhibitor

Basic Description

Synonyms	Takinib\|1111556-37-6\|EDHS-206\|3-N-(1-propylbenzimidazol-2-yl)benzene-1,3-dicarboxamide\|Z56NTB3YHJ\|N1-(1-Propyl-1H-benzo[d]imidazol-2-yl)isophthalamide\|MFCD11822633\|1,3-Benzenedicarboxamide, N1-(1-propyl-1H-benzimidazol-2-yl)-\|N1-(1-Propyl-1H-benzimidazol-
Specifications & Purity	≥98%(HPLC)
Storage Temp	Store at -20°C
Shipped In	Ice chest + Ice pads
Grade	Moligand™
Action Type	INHIBITOR
Mechanism of action	Inhibitor of CDC like kinase 2;Inhibitor of interleukin 1 receptor associated kinase 1;Inhibitor of interleukin 1 receptor associated kinase 4;Inhibitor of mitogen-activated protein kinase kinase kinase 7
Product Description	Application Takinib has been used as an inhibitor of transforming 28 growth factor - β-activated kinase -1 (TAK-1) in human leukemia monocytic THP-1 cells. It may be used as a TAK1 inhibitor in Jurkat cells.

Associated Targets

IRAK4 Tchem Interleukin-1 receptor-associated kinase 4 1 Activities

Discover Target: IRAK4

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

IRAK1 Tchem Interleukin-1 receptor-associated kinase 1 1 Activities

Discover Target: IRAK1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

MAP3K7 Tchem Mitogen-activated protein kinase kinase kinase 7 1 Activities

Discover Target: MAP3K7

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CLK2 Tchem Dual specificity protein kinase CLK2 1 Activities

Discover Target: CLK2

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Names and Identifiers

IUPAC Name	3-N-(1-propylbenzimidazol-2-yl)benzene-1,3-dicarboxamide
INCHI	InChI=1S/C18H18N4O2/c1-2-10-22-15-9-4-3-8-14(15)20-18(22)21-17(24)13-7-5-6-12(11-13)16(19)23/h3-9,11H,2,10H2,1H3,(H2,19,23)(H,20,21,24)
InChi Key	UOZVVPXKJGOFIG-UHFFFAOYSA-N
Canonical SMILES	CCCN1C2=CC=CC=C2N=C1NC(=O)C3=CC=CC(=C3)C(=O)N
Isomeric SMILES	CCCN1C2=CC=CC=C2N=C1NC(=O)C3=CC=CC(=C3)C(=O)N
Alternate CAS	1111556-37-6
PubChem CID	37750349
MeSH Entry Terms	EDHS-206;takinib
Molecular Weight	322.37

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot Number	Certificate Type	Date	Item
C2301324	Certificate of Analysis	Sep 06, 2022	T288176
C2301325	Certificate of Analysis	Sep 06, 2022	T288176
C2301326	Certificate of Analysis	Sep 06, 2022	T288176
C2301328	Certificate of Analysis	Sep 06, 2022	T288176
C2301329	Certificate of Analysis	Sep 06, 2022	T288176

Safety and Hazards(GHS)

Pictogram(s)	GHS07
Signal	Warning
Hazard Statements	H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed
Precautionary Statements	P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell.
RIDADR	NONHforallmodesoftransport

References

1. Totzke J, Gurbani D, Raphemot R, Hughes PF, Bodoor K, Carlson DA, Loiselle DR, Bera AK, Eibschutz LS, Perkins MM et al.. (2017) Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.. Cell Chem Biol, 24 (8): (1029-1039.e7). [PMID:28820959]
2. Scarneo SA, Mansourati A, Eibschutz LS, Totzke J, Roques JR, Loiselle D, Carlson D, Hughes P, Haystead TAJ. (2018) Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion.. Sci Rep, 8 (1): (17058). [PMID:30451876]

Solution Calculators

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.